George Frangeskides, Exec-Chair at Alba Mineral Resources, discusses grades at the Clogau Gold Mine. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXeris Biopharma Regulatory News (0A8E)

Share Price Information for Xeris Biopharma (0A8E)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.080876
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 2.080876
0A8E Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Invesco ltd: Form 8.3 - Xeris Pharmaceuticals Inc.

10 Jun 2021 14:31

Invesco ltd: Form 8.3 - Xeris Pharmaceuticals Inc.

Form 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

KEY INFORMATION
Name of person dealing (Note 1)Invesco Ltd.
Company dealt inXeris Pharmaceuticals, Inc.
Class of relevant security to which the dealings being disclosed relate (Note 2)Common Stock US98422L1070
Date of dealing09-06-2021
INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

 LongShort
 Number (%)Number  (%)
(1) Relevant securities2,047,539 3.085%  
(2) Derivatives (other than options)  
(3) Options and agreements to purchase/sell  
Total2,047,539 3.085% 

Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:LongShort
 No. (%)Number  (%)
(1) Relevant securities  
(2) Derivatives (other than options)  
(3) Options and agreements to purchase/sell  
Total  

1. DEALINGS (Note 4)(a) Purchases and sales

Purchase/saleNumber of relevant securitiesPrice per unit (Note 52
Purchase2,6004.01 USD
   
   

(b) Derivatives transactions (other than options transactions)

Product name,e.g. CFDNature of transaction(Note 6)Number of relevant securities(Note 7)Price per unit(Note 5)
    

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,e.g. call optionWriting, selling, purchasing, varying etc.Number of securities to which the option relates (Note 7)Exercise priceType, e.g. American, European etc.Expiry dateOption money paid/received per unit (Note 5)
       

(ii) Exercising

Product name,e.g. call optionNumber of securitiesExercise price per unit (Note 5)
   

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction(Note 8)DetailsPrice per unit(if applicable) (Note 5)
   

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

Is a Supplemental Form 8 attached? (Note 9) NO

Date of disclosure10-06-2021
Contact namePhilippa Holmes
Telephone number+44 1491 417447
If a connected EFM, name of offeree/offeror with which connectedN/A
If a connected EFM, state nature of connection (Note 10) 

Date   Source Headline
7th Oct 20213:09 pmRNSXeris Pharmaceuticals, Inc 8.3
6th Oct 20212:43 pmRNSXeris Pharmaceuticals, Inc 8.3
6th Oct 20212:42 pmRNSForm 8.3 - Xeris Pharmaceuticals, Inc
5th Oct 20215:06 pmRNSXeris Pharmaceuticals, Inc 8.3 Amend
5th Oct 20213:15 pmRNSXeris Pharmaceuticals, Inc 8.3
4th Oct 20211:04 pmRNSXeris Pharmaceuticals, Inc 8.3
1st Oct 20213:05 pmRNSXeris Pharmaceuticals, Inc 8.3
1st Oct 202110:14 amRNSForm 8.3 - XERIS PHARMACEUTICALS INC
30th Sep 20215:07 pmRNSXeris Pharmaceuticals, Inc 8.3
30th Sep 20212:58 pmRNSXeris Pharmaceuticals, Inc 8.3
30th Sep 202110:22 amRNSForm 8.3 - XERIS PHARMACEUTICALS INC
29th Sep 20212:36 pmRNSXeris Pharmaceuticals, Inc 8.3
28th Sep 20212:22 pmRNSXeris Pharmaceuticals, Inc 8.3
28th Sep 20212:21 pmRNSForm 8.3 - Xeris Pharmaceuticals, Inc
28th Sep 20212:19 pmRNSForm 8.3 - Xeris Pharmaceuticals, Inc
27th Sep 202112:27 pmRNSXeris Pharmaceuticals, Inc 8.3
24th Sep 20214:35 pmRNSXeris Pharmaceuticals, Inc 8.3
24th Sep 20211:05 pmRNSForm 8.3 - Xeris Pharmaceuticals, Inc
23rd Sep 20212:35 pmRNSXeris Pharmaceuticals, Inc 8.3
23rd Sep 20212:18 pmEQSForm 8.3 - The Vanguard Group, Inc.: Xeris Pharmaceuticals, Inc
22nd Sep 20213:00 pmRNSXeris Pharmaceuticals, Inc 8.3
22nd Sep 20212:12 pmEQSForm 8.3 - The Vanguard Group, Inc.: Xeris Pharmaceuticals, Inc
22nd Sep 202112:18 pmRNSForm 8.3 - XERIS PHARMACEUTICALS INC
21st Sep 20213:03 pmRNSXeris Pharmaceuticals, Inc 8.3
21st Sep 20212:17 pmEQSForm 8.3 - The Vanguard Group, Inc.: Xeris Pharmaceuticals, Inc
21st Sep 20211:40 pmRNSForm 8.3 - Xeris Pharmaceuticals, Inc
20th Sep 20211:53 pmEQSForm 8.3 - The Vanguard Group, Inc.: Xeris Pharmaceuticals, Inc
20th Sep 202112:29 pmRNSXeris Pharmaceuticals, Inc 8.3
20th Sep 202112:14 pmGNWInvesco ltd: Form 8.3 - Xeris Pharmaceutical Inc.
17th Sep 20213:20 pmRNSForm 8.3 - Xeris Pharmaceuticals, Inc.
17th Sep 20212:51 pmRNSXeris Pharmaceuticals, Inc 8.3
17th Sep 20212:05 pmRNSForm 8.3 - Xeris Pharmaceuticals, Inc
17th Sep 20211:13 pmEQSForm 8.3 - The Vanguard Group, Inc.: Xeris Pharmaceuticals, Inc.
16th Sep 20213:20 pmRNSForm 8.3 - Xeris Pharmaceuticals, Inc.
16th Sep 20212:46 pmRNSXeris Pharmaceuticals, Inc 8.3
16th Sep 20211:58 pmGNWInvesco Ltd: Form 8.3 - Xeris Pharmaceutical Inc
16th Sep 202110:52 amRNSForm 8.3 - XERIS PHARMACEUTICALS INC
15th Sep 20211:58 pmRNSXeris Pharmaceuticals, Inc 8.3
15th Sep 202111:15 amRNSForm 8.3 - XERIS PHARMACEUTICALS INC
15th Sep 202111:14 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
14th Sep 20212:24 pmRNSXeris Pharmaceuticals, Inc 8.3
14th Sep 20211:56 pmRNSMan Group PLC : Form 8.3 - Strongbridge biopharma plc
14th Sep 20211:03 pmRNSForm 8.3 - The Vanguard Group, Inc.: Xeris Pharmaceuticals, Inc.
13th Sep 202112:22 pmRNSXeris Pharmaceuticals, Inc 8.3
13th Sep 202112:15 pmGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
10th Sep 20212:42 pmRNSXeris Pharmaceuticals, Inc 8.3
10th Sep 20217:21 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
9th Sep 20211:49 pmRNSXeris Pharmaceuticals, Inc 8.3
9th Sep 202111:15 amRNSForm 8.3 - Xeris Pharmaceuticals, Inc
9th Sep 202111:13 amRNSForm 8.3 - XERIS PHARMACEUTICALS INC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.